CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Placebo + PlaceboWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (6)


Name (Synonyms) Correlation
drug509 Hydroxychloroquine + Placebo Wiki 1.00
drug131 BNT162b1 Wiki 0.71
drug133 BNT162c2 Wiki 0.71
drug508 Hydroxychloroquine + Azithromycin Wiki 0.71
drug130 BNT162a1 Wiki 0.71
drug132 BNT162b2 Wiki 0.71

Correlated MeSH Terms (5)


Name (Synonyms) Correlation
D012327 RNA Virus Infections NIH 0.50
D012141 Respiratory Tract Infections NIH 0.23
D014777 Virus Diseases NIH 0.14
D003141 Communicable Diseases NIH 0.11
D007239 Infection NIH 0.07

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0011947 Respiratory tract infection HPO 0.23

There is one clinical trial.

Clinical Trials


1 Qatar Prospective RCT Of Therapy Eliminating Covid Transmission

Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.

NCT04349592 Covid19 Drug: Hydroxychloroquine + Azithromycin Drug: Hydroxychloroquine + Placebo Other: Placebo + Placebo

Primary Outcomes

Description: Days

Measure: Proportion of virologically cured (no virus detected) cases at day 6

Time: Day 6

Secondary Outcomes

Description: Days

Measure: The dichotomous virologic shedding endpoint as assessed at two weeks after study entry

Time: 2 weeks

Description: Days

Measure: Quantitative viral load (assessed with each virology testing set)

Time: Day 1 to 21


No related HPO nodes (Using clinical trials)